COMMUNIQUÉS West-GlobeNewswire

Kintai Therapeutics Appoints Senior Executive Dr. Mark E. Nuttall as Chief Business Officer
11/09/2019
CAMBRIDGE, Mass. , Sept. 11, 2019 (GLOBE NEWSWIRE) -- Kintai Therapeutics, a biotech company pioneering precision medicines by unlocking the power of the enteric signaling network, today announced the appointment of [...]
Emerald Health Therapeutics Forms Partnership With HelloMD to Continue Expanding its Medical Cannabis Patient Program
11/09/2019
New partner-integrated platform to further streamline patient access to medical advice, enhancing Emerald’s patient experience and driving medical expansion VANCOUVER, British Columbia, Sept. 11, 2019 (GLOBE NEWSWIRE [...]
Athenex Announces Initiation of Phase I Clinical Study in China of KX2-361 Oral by Partner Guangzhou Xiangxue Pharmaceutical
11/09/2019
BUFFALO, N.Y., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
Exactus, Inc. Announces Participation in the Investor Summit and the Sidoti & Company Fall 2019 Conference
11/09/2019
DELRAY BEACH, Fla., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Exactus, Inc. (OTCQB:EXDI) (the “Company”), a farmer and manufacturer of hemp-derived phytocannabinoid products, today announced that management will present at the [...]
Capital Senior Living Corporation Grants Executive Vice President and Chief Operating Officer Brandon M. Ribar Inducement Awards Pursuant to NYSE Rule 303A.08
11/09/2019
DALLAS, Sept. 11, 2019 (GLOBE NEWSWIRE) -- Capital Senior Living Corporation (the “Company”) (NYSE: CSU), one of the nation’s largest operators of senior housing communities, today announced that on September 10, 2019 ( [...]
New Data Presented at ECTRIMS Reinforce Long-term Benefits of TECFIDERA® (dimethyl fumarate) Over 10 Years
11/09/2019
TECFIDERA consistently maintained low levels of disease activity with no increased risk in adverse events over a decade of treatment Latest interim data from Phase 3 EVOLVE-MS-1 trial show Biogen and Alkermes’ [...]
Trading in Coloplast shares by board members, executives or associated persons
11/09/2019
Please see enclosed pdf. Attachment 11092019_trading in shares_NP
Trading in Coloplast shares by board members, executives or associated persons
11/09/2019
Please see enclosed pdf. Attachment 11092019_trading in shares_GL
Major shareholder announcement
11/09/2019
Company announcement 11 September 2019 Major shareholder announcement Pursuant to section 30 of Consolidated Act no. 459 of 24 April 2019 on capital markets, as amended, NeuroSearch A/S ("NeuroSearch") hereby announces [...]
Zealand Pharma completes subscription of new shares and registration of capital increase
11/09/2019
Company announcement – No. 33 / 2019 Zealand Pharma completes subscription of new shares and registration of capital increase Copenhagen, September 11, 2019 – With reference to the company announcement no. 30/2019 dated [...]
Trading in GN Store Nord shares by board members, executives and associated persons
11/09/2019
GN Store Nord has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in GN Store Nord made by persons discharging managerial responsibilities in GN [...]
Emerald Health Therapeutics annonce un financement de parts de débentures convertibles de 25 millions USD
11/09/2019
CE COMMUNIQUÉ DE PRESSE NE DOIT PAS ÊTRE DISTRIBUÉ AUX AGENCES DE PRESSE AMÉRICAINES ET NE DOIT PAS ÊTRE DIFFUSÉ AUX ÉTATS-UNIS VANCOUVER, Colombie-Britannique, 10 sept. 2019 (GLOBE NEWSWIRE) -- Emerald Health [...]
Digirad Corporation Acquires ATRM Holdings, Inc.
10/09/2019
Transforms into a Diversified Holding Company Completes Private Placement of Preferred Stock for $3.0 Million SUWANEE, Ga., Sept. 10, 2019 (GLOBE NEWSWIRE) -- Digirad Corporation (NASDAQ: DRAD) (“Digirad” or the “ [...]
Kane Biotech Releases Inaugural Business Update Video
10/09/2019
WINNIPEG, Manitoba, Sept. 10, 2019 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V: KNE), (the “Corporation” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of [...]
Update regarding registration of new shares for Zealand Pharma
10/09/2019
Company announcement – No. 32 / 2019 Update regarding registration of new shares for Zealand Pharma Copenhagen, September 10, 2019 – In reference to Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78) [...]
T2 Biosystems to Host Conference Call to Discuss Awarding of Multi-Million Dollar BARDA Contract
10/09/2019
Contract includes initial phase valued at $6 million, with a total value up to $69 million Call will also cover restructuring of CRG term loan agreement and Breakthrough Technology contract with Premier Inc. Company to [...]
Adamas Announces New Employment Inducement Grant
10/09/2019
EMERYVILLE, Calif., Sept. 10, 2019 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the company’s board of directors granted four new employees the [...]
T2 Biosystems Announces Restructuring of CRG Term Loan Agreement
10/09/2019
Extends Interest-Only Payment Period Through December 2022 and Reduces Minimum Revenue Targets LEXINGTON, Mass., Sept. 10, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of [...]
SeaSpine to Present at the Ladenburg Thalmann 2019 Healthcare Conference
10/09/2019
CARLSBAD, Calif., Sept. 10, 2019 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced [...]

Pages